Shelter Pharma Ltd — Important, 15-12-2025: Company Update
15-12-2025 | 02:55 pm
15-12-2025 | 02:55 pm
Shelter Pharma has launched D3 Cure Capsules, significantly expanding its Nutraceutical portfolio to target the rapidly growing international wellness market. These capsules primarily address vitamin D deficiency, crucial for calcium and phosphorus absorption, which supports overall health. Key benefits include improved bone health, enhanced immune function, better mood, and support for muscle and cardiovascular systems. This strategic launch aims to strengthen Shelter Pharma's presence in the preventive healthcare segment, contributing positively to its growth and delivering long-term value for shareholders.
No comments yet. Be the first to comment!
